Chapter 30 Arthritis, Gout Flashcards
aspirin and other salicylates
- NSAID
- used for pain, fever, inflammation
- inhibits COX nonspecifically in peripheral tissues and CNS
- longer effect on TXA2 and platelet aggregation
- prophylaxis against MI, CVA, thromboembolism
- avoid in children (reye syndrome)
- AE: GI bleeding, ulceration, tinnitus, hypersensitivity in asthma
acetaminophen (tylenol)
- NSAID
- analgesic and antipyretic
- safe for children
- weak anti-inflammatory
- preferred for gestational
- AE: risk of renal insufficiency with long term use
acetylcysteine (sulfhydryl antidote)
- extensive hepatic metabolism, toxic doses deplete hepatic glutathione which leads to APAP OD
- antidote supplants the glutathione and inactivates toxic metabolite
ketorolac (toradol)
- NSAID
- analgesic, antipyretic, anti inflammatory
- reversibly, non-selectively inhibit COX isoenzymes
- don’t use IV more than 3-5 days, can cause GI issue
- AE: gastric irritation, nausea, dyspepsia, PUD, hepatotoxicity, nephrotoxicity
ibuprofen, naproxen
- NSAID
- analgesic, antipyretic, anti inflammatory
- reversibly, non-selectively inhibit COX isoenzymes
- AE: gastric irritation, nausea, dyspepsia, PUD, hepatotoxicity, nephrotoxicity
caldolor
ibuprofen injection formula
ofirmev
- IV tylenol
- not cost effective
- use suppository if NPO
celecoxib (celebrex)
- NSAID
- COX2 inhibitor
- analgesic, antipyretic, anti inflammatory
- no inhibition of platelet aggregation
- AE: CV event, diarrhea, dyspepsia, ABD pain,
auranofin (ridaura)
- DMARD (disease modifying anti-rheumatic drug)
- slow joint erosion in RA
- gold salt
- benefit 3-6 months after therapy starts
- AE: hematologic, dermatologic, GI, renal, flushing, hypotension, tachycardia, rash, stomatitis
gold sodium thiomalate (myochrysine, aurolate)
- DMARD (disease modifying anti-rheumatic drug)
- slow joint erosion in RA
- gold salt
- benefit 3-6 months after therapy starts
- AE: hematologic, dermatologic, GI, renal, flushing, hypotension, tachycardia, rash, stomatitis
prednisone (deltasone)
- glucocorticoid
- DMARD
- act more rapidly than other DMARDs
- long term use inhibited by serious AE
- short course therapy for initiation or flare up
methotrexate (rheumatrex)
- single most effective DMARD available
- benefits early as 2-3 weeks
- folic acid supplement may reduce AE without compromising efficacy
- AE: GI, hematologic, pulmonary, increase LFT, teratogenic
leflunomide (arava)
- DMARD
- alternative to methotrexate for 1st line Rx
- AE: diarrhea, reversible alopecia, increase LFT, increase hepatoxicity when combined with MTX, teratogenic
hydroxychloroquine (plaquenil)
- antimalarial and DMARD
- up to 6 months to see benefit
- AE: GI, blurred vision, night blindness
etanercept (enbrel)
- DMARD
- reserved for RA refractory to MTX and other DMARDs
infliximab (remicade)
- DMARD
- used in crohn’s and RA
probenecid (benemid)
- uricosuric used to prevent gout in those who under excrete uric acid
- competitively inhibits reabsorption
- effects may be blunted by ASA
allopurinol (zyloprim)
- xanthine oxidase inhibitor
- prevent gout attacks in those who overproduce uric acid
- AE: not tolerate by 25% of pts, N/V, hepatitis, skin rash, hypersensitivity
febuxostat (uloric)
- xanthine oxidase inhibitor
- used to prevent gout attacks in those who overproduce uric acid
- daily dosing with greater efficacy
- AE: increase LFT, nausea, arthralgias, rash
pegloticase (krystexxa)
rasburicase (elitek)
- catabolic enzyme preparation for gout
- breakdown uric acid
- krystexxa 30k vs elitek 4k
indomethacin (indocin)
- NSAID
- acute gout attack
colchicine (colcrys)
- acute gout attack
- blocks urate crystal-induced inflammation
- AE: N/V, diarrhea, ABD cramps
- tolerance limits use
- diarrhea is dose limiting and requires dose titration
sulindac
- NSAID
- COX 1 and 2 inhibitor
piroxicam (feldene)
- NSAID
- treat RA and OA
- COX 1/2 inhibitor
nabumetone
- NSAID
- manage RA/OA
- COX 1/2 inhibitor
etodolac
- NSAID
- RA, OA, juvenile idiopathic arthritis
- COX 1/2 inhibitor
meloxicam (mobic)
- NSAID
- RA, OA, JIA
- COX 1/2 inhibitor
diclofenac (voltaren)
- NSAID
- COX 1/2 inhibitor
adalimumab (humira)
- DMARD
- subQ injection
anakinra (kineret)
- DMARD
- subQ injection
abatecept (orencia)
- DMARD
- IV infusion or subQ
tocilizumab (actemra)
- DMARD
- IV or subQ
certolizumab (cimzia)
-DMARD
golimumab (simponi)
-DMARD
penicillamine (cuprimine)
- chelating agent
- wilson’s disease, severe/active RA
sulfasalazine (azulifidine)
- 5 aminosalicylic acid derivative
- RA
rasburicase (elitek)
- urate oxidase enzyme
- manage uric acid levels